416 related articles for article (PubMed ID: 35432269)
1. COPD and Gut-Lung Axis: How Microbiota and Host Inflammasome Influence COPD and Related Therapeutics.
Qu L; Cheng Q; Wang Y; Mu H; Zhang Y
Front Microbiol; 2022; 13():868086. PubMed ID: 35432269
[TBL] [Abstract][Full Text] [Related]
2. Imbalance of gut microbiota is involved in the development of chronic obstructive pulmonary disease: A review.
Song W; Yue Y; Zhang Q
Biomed Pharmacother; 2023 Sep; 165():115150. PubMed ID: 37429232
[TBL] [Abstract][Full Text] [Related]
3. Microbiome Links Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease and Dietary Fiber via the Gut-Lung Axis: A Narrative Review.
Ding K; Chen J; Zhan W; Zhang S; Chen Y; Long S; Lei M
COPD; 2021 Dec; 19(1):10-17. PubMed ID: 34963421
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease.
Lim EY; Song EJ; Shin HS
J Microbiol Biotechnol; 2023 Sep; 33(9):1111-1118. PubMed ID: 37164760
[TBL] [Abstract][Full Text] [Related]
5. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
6. Gut-lung Microbiota Interactions in Chronic Obstructive Pulmonary Disease (COPD): Potential Mechanisms Driving Progression to COPD and Epidemiological Data.
De Nuccio F; Piscitelli P; Toraldo DM
Lung; 2022 Dec; 200(6):773-781. PubMed ID: 36241745
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota, in the Halfway between Nutrition and Lung Function.
Espírito Santo C; Caseiro C; Martins MJ; Monteiro R; Brandão I
Nutrients; 2021 May; 13(5):. PubMed ID: 34069415
[TBL] [Abstract][Full Text] [Related]
8. The treatment of Qibai Pingfei Capsule on chronic obstructive pulmonary disease may be mediated by Th17/Treg balance and gut-lung axis microbiota.
Jia Y; He T; Wu D; Tong J; Zhu J; Li Z; Dong J
J Transl Med; 2022 Jun; 20(1):281. PubMed ID: 35729584
[TBL] [Abstract][Full Text] [Related]
9. Lung microbiome, gut-lung axis and chronic obstructive pulmonary disease.
Gokulan K; Joshi M; Khare S; Bartter T
Curr Opin Pulm Med; 2022 Mar; 28(2):134-138. PubMed ID: 34907959
[TBL] [Abstract][Full Text] [Related]
10. COPD and the gut-lung axis: the therapeutic potential of fibre.
Vaughan A; Frazer ZA; Hansbro PM; Yang IA
J Thorac Dis; 2019 Oct; 11(Suppl 17):S2173-S2180. PubMed ID: 31737344
[TBL] [Abstract][Full Text] [Related]
11. The Bidirectional Gut-Lung Axis in Chronic Obstructive Pulmonary Disease.
Wang L; Cai Y; Garssen J; Henricks PAJ; Folkerts G; Braber S
Am J Respir Crit Care Med; 2023 May; 207(9):1145-1160. PubMed ID: 36883945
[TBL] [Abstract][Full Text] [Related]
12. A new perspective on gut-lung axis affected through resident microbiome and their implications on immune response in respiratory diseases.
Xu C; Hao M; Zai X; Song J; Huang Y; Gui S; Chen J
Arch Microbiol; 2024 Feb; 206(3):107. PubMed ID: 38368569
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory
Lai HC; Lin TL; Chen TW; Kuo YL; Chang CJ; Wu TR; Shu CC; Tsai YH; Swift S; Lu CC
Gut; 2022 Feb; 71(2):309-321. PubMed ID: 33687943
[TBL] [Abstract][Full Text] [Related]
14. The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy.
Liu X; Cheng Y; Zang D; Zhang M; Li X; Liu D; Gao B; Zhou H; Sun J; Han X; Lin M; Chen J
Front Oncol; 2021; 11():720842. PubMed ID: 34490119
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota and Lung Injury.
Tan JY; Tang YC; Huang J
Adv Exp Med Biol; 2020; 1238():55-72. PubMed ID: 32323180
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota: A new insight into lung diseases.
Ma PJ; Wang MM; Wang Y
Biomed Pharmacother; 2022 Nov; 155():113810. PubMed ID: 36271581
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Role of Gut-Lung Interactions in COPD Pathogenesis: A Comprehensive Review on Microbiota Characteristics and Inflammation Modulation.
Cheng ZX; Zhang J
Chronic Obstr Pulm Dis; 2024 May; 11(3):311-325. PubMed ID: 38563747
[TBL] [Abstract][Full Text] [Related]
18. The Microbiome in COPD: Emerging Potential for Microbiome-Targeted Interventions.
Millares L; Monso E
Int J Chron Obstruct Pulmon Dis; 2022; 17():1835-1845. PubMed ID: 35983167
[TBL] [Abstract][Full Text] [Related]
19. Role of Short-Chain Fatty Acids Produced by Gut Microbiota in Innate Lung Immunity and Pathogenesis of the Heterogeneous Course of Chronic Obstructive Pulmonary Disease.
Kotlyarov S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563159
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Pulmonary Microbiota to Fight against Respiratory Diseases.
Li Z; Li Y; Sun Q; Wei J; Li B; Qiu Y; Liu K; Shao D; Ma Z
Cells; 2022 Mar; 11(5):. PubMed ID: 35269538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
